Christopher Murawsky

Christopher Murawsky, Ph.D., is a seasoned researcher with extensive experience in biotechnology and immunology. Currently serving as the Director of Research at Amgen, Christopher leads a multi-functional team in the discovery of modular domains for T cell engagers and other therapeutic projects. Prior roles at Amgen included Senior Principal Scientist and Principal Scientist, where Christopher focused on antibody repertoire engineering and the development of therapeutic antibodies utilizing high throughput screening technologies. Previous experience includes cancer research as a Postdoctoral Fellow at The Salk Institute and doctoral studies at the University of Cambridge, where Christopher investigated embryonic development and cell cycle control. Christopher holds a Ph.D. in Molecular Biology from the University of Cambridge, and degrees from McGill University and The University of British Columbia.